CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
Location status: Recruiting
NCT Number: NCT06585085
Our main objective is to evaluate the intervention that best enables women's adherence to physical activity (PA).
Our hypothesis is that identifying types of interventions suitable for pregnant women (in-person PA sessions, videoconferences or mixed format) could help improve their PA level and simultaneously reduce their sedentary behavior (SB).
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Clermont-Ferrand, 63000, France
Location status: Recruiting
PA has beneficial effects on physical, psychological, and social health, and its regular practice helps to prevent numerous chronic diseases. During pregnancy, PA also has many benefits for women's physical condition, weight gain, gestational hypertension, lower back and pelvic pain, and postpartum depressive symptoms and may also reduce fetal macrosomia and positively affect neurogenesis, language development, memory, and other learning-associated cognitive functions. (CNSF 2021). PA is thus recommended to all pregnant women for 150 to 180 minutes a week, adapted to their health status, physical condition, and course of pregnancy. It is also recommended that women limit their Sedentary Behaviour (SB) (to ≤7 waking h/day) during pregnancy.
No French study has assessed the impact of a PA program during pregnancy, and no published study has proposed videoconference PA sessions during pregnancy. Pregnant women's adherence to PA is a limiting factor found in many interventional studies. Possible changes in maternal behavior in practicing PA and reducing SB during pregnancy could also favorably affect the health of mother and child and thus subsequent PA. Given PA's many benefits and SB's harmful effects during pregnancy, assessing programs that enable pregnant women to both increase PA levels and reduce SB seems pertinent and valuable.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Non inclusion Criteria:
Group B women will have access to a weekly program of 3 face-to-face PA sessions. The face-to-face sessions will be offered at one or more locations in the Clermont-Ferrand area, depending on the number of groups taking part. They will also be offered at one or more times depending on the number of groups. Locations and times will be specified on the online booking software. Women can only register for 3 sessions per week.
Women in Group C will have access to a weekly program of 3 PA sessions via interactive videoconferencing. These sessions will have the same format as the face-to-face sessions with visualization of the APA professional, visualization of the participants (who can also choose to be masked). The PA professional will also see the participants, so he or she can correct positions and give individualized advice at any time. Schedules will be specified on the online booking software with the videoconference link. Women can only register for 3 sessions per week.
Women in Group D will have access to a weekly program of 3 mixed-format PA sessions, with 2 interactive distance learning sessions and 1 in-person session. The in-person sessions will be offered at one or more locations in the Clermont-Ferrand area, depending on the number of groups taking part. Locations and times will be specified on the online booking software. Women can only register for 1 face-to-face session per week. The other 2 sessions will be offered via interactive videoconferencing. These sessions will have the same format as the in-person sessions, with visualization of the APA professional, visualization of the participants. The APA professional will also see the participants, so he or she can correct positions and give individualized advice at any time. Schedules will be specified on the online booking software with the videoconference link. Women can only register for 2 videoconference's sessions per week.
Time frame: between 24 and 30 weeks of gestation
measurement of the PA level, measured by accelerometer, expressed in MET.minutes/week by wearing a tri-axial accelerometer on the hip
Time frame: between 24 and 30 weeks of gestation
measurement of sedentary time (defined as a state of wakefulness characterized by an energy expenditure less than or equal to 1.5 METs) between getting up and going to bed using a tri-axial hip accelerometer
Time frame: After 39 weeks of gestation, end of planned participation in sessions
For women in groups B, C and D, rate of sessions completed on the number of eligible sessions according to their randomization group and the socio-demographic criteria
Time frame: at 4 distinct times: between 24+0d and 30+0d weeks of gestation, between 32+0d and 37+6d weeks of gestation, between 6 and 10 weeks postpartum and between 20 and 24 weeks postpartum
PA time measured with a tri-axial accelerometer at the hip
Time frame: at 4 distinct times: between 24 and 30 weeks of gestation, between 32+0day and 37+6day weeks of gestation, between 6 and 10 weeks postpartum and between 20 and 24 weeks postpartum
sedentary time (defined as wakefulness characterized by an energy expenditure less than or equal to 1.5 METs) between getting up and going to bed will be compared according to each intervention modality. Sedentary behavior will be measured by wearing a tri-axial accelerometer on the hip
Time frame: during the 31 days after at the inclusion in the study and between 35 and 39 weeks of gestation
Qualitative study by means of semi-structured telephone interviews with a minimum of 100 women, i.e. a minimum of 25 women per group, a number to be adapted according to the data saturation that will be obtained
Time frame: At delivery
occurrence of maternal pathology during pregnancy (gestational arterial hypertension [PAS ≥ 140 mm Hg and a PAD ≥ 90 mm Hg occurring after 20 weeks of gestation] and/or, pre-eclampsia [hypertension with albuminuria > 0.3g/L per 24 hours] and/or gestational diabetes diagnosed by orally induced hyperglycaemia after 23 SA)
Time frame: At delivery
occurrence of maternal pathology during pregnancy (gestational arterial hypertension [PAS ≥ 140 mm Hg and a PAD ≥ 90 mm Hg occurring after 20 weeks of gestation] and/or, pre-eclampsia [hypertension with albuminuria > 0.3g/L per 24 hours] and/or gestational diabetes diagnosed by orally induced hyperglycaemia after 23 SA)
Time frame: 24 hours after delivery
A composite criterion: "occurrence of 3rd or 4th degree perineal lesions and/or occurrence of immediate postpartum haemorrhage (blood loss > 500mL in the 24 hours after delivery)"
Time frame: 24 hours after delivery
A composite criterion: "occurrence of 3rd or 4th degree perineal lesions and/or occurrence of immediate postpartum haemorrhage (blood loss > 500mL in the 24 hours after delivery)"
Time frame: 6 months postpartum
: presence of a depressive state assessed by the Edinburgh Depression Scale (EPDS) (with a discriminant threshold of the EPDS ≥ 11)
Time frame: 6 months postpartum
: presence of a depressive state assessed by the Edinburgh Depression Scale (EPDS) (with a discriminant threshold of the EPDS ≥ 11)
Time frame: 4 weeks postpartum
Evaluation using the Questionnaire for Assessing the Childbirth Experience (QACE)
Time frame: 4 weeks postpartum
Evaluation using the Questionnaire for Assessing the Childbirth Experience (QACE)
Time frame: between 24 and 30 weeks of gestation
Score obtained in the WHOQOL-Bref questionnaire
Time frame: between 24 and 30 weeks of gestation
Score obtained in the WHOQOL-Bref questionnaire
Time frame: between 32 and 37 SA+6day weeks of gestation
Score obtained in the WHOQOL-Bref questionnaire
Time frame: between 32 and 37 SA+6day weeks of gestation
Score obtained in the WHOQOL-Bref questionnaire
Time frame: between 6 and 10 weeks postpartum
Score obtained from the WHOQOL-Bref questionnaire
Time frame: between 6 and 10 weeks postpartum
Score obtained from the WHOQOL-Bref questionnaire
Time frame: between 20 and 24 weeks postpartum
Score obtained from the WHOQOL-Bref questionnaire
Time frame: between 20 and 24 weeks postpartum
Score obtained from the WHOQOL-Bref questionnaire
Time frame: between 24 and 30 weeks of gestation
ICIQ-SF questionnaire score - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
Time frame: between 24 and 30 weeks of gestation
ICIQ-SF questionnaire score - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
Time frame: between 32 and 37 SA+6day weeks of gestation
ICIQ-SF questionnaire score - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
Time frame: between 32 and 37 SA+6day weeks of gestation
ICIQ-SF questionnaire score - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
Time frame: between 20 and 24 weeks postpartum
Score on the ICIQ-SF questionnaire - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
Time frame: between 20 and 24 weeks postpartum
Score on the ICIQ-SF questionnaire - International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form
Time frame: between 20 and 24 weeks postpartum
Score on the FSFI Female Sexual Function Index questionnaire
Time frame: between 20 and 24 weeks postpartum
Score on the FSFI Female Sexual Function Index questionnaire
Time frame: At delivery
a composite criterion: "Apgar score <7 at 5 min and/or arterial pH <7.10 and/or transfer and/or intra-hospital transfer to a neonatal unit"
Time frame: At delivery
a composite criterion: "Apgar score <7 at 5 min and/or arterial pH <7.10 and/or transfer and/or intra-hospital transfer to a neonatal unit"
Time frame: At delivery
occurence of large for gestational age newborns (birth weight greater than the 95th percentile according to gestational age according to Audipog curves)
Time frame: At delivery
occurence of large for gestational age newborns (birth weight greater than the 95th percentile according to gestational age according to Audipog curves)
Time frame: Data collected during the pregnancy and until 2 month of post-partum
Cost-effectiveness incremental study (including modelling of the gains linked to the reduction in C-section)
Time frame: Data collected during the pregnancy and until 6 month of post-partum
Cost-utility study (based on the usefulness felt by women) from the point of view of health insurance using the EQ5D-5L (5 Level Euroqol 5 Dimensions) and a mapping analysis of the WHOQOL-Bref
Contact information is provided by the study sponsor or research team.
University Hospital, Clermont-Ferrand
Other
Care Pathway Organization in Order to Increase Physical Activity Levels and Limit Sedentary Behavior During Pregnancy: a Randomized Controlled Trial
Acronym: PREGMOUV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07651709
Bone Health, Brain Diseases
Zhejiang, China
View Trial DetailsNCT05945225
Gingival Diseases, Gingivitis
Nancy, France
View Trial DetailsNCT07175597
Cardiovascular Diseases, Hypertension
Cuernavaca, Morelos, Mexico
View Trial DetailsNCT06653907
Endocrine System Diseases, Pregnancy Outcomes
Shijiazhuang, Heibei, China
View Trial Details